Question 1

Is Human-Menopausal-Gonadotrophin currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Human-Menopausal-Gonadotrophin has 10 active shortage notices across 4 countries (United States, Belgium, European Union, Singapore). Status is refreshed daily from official regulatory sources.

Question 2

Why is Human-Menopausal-Gonadotrophin in shortage?

Accepted Answer

Regulators attribute the current Human-Menopausal-Gonadotrophin shortages to manufacturing problems, causes not stated by the regulator, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Human-Menopausal-Gonadotrophin shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 4 May 2026 to 30 Sept 2030, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Human-Menopausal-Gonadotrophin shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United States	critical	2	29 Dec 2015	—	FDA MedWatch
Belgium	high	5	1 Jan 2020	30 Sept 2030	FAMHP

Human-Menopausal-Gonadotrophin shortage status

Where Human-Menopausal-Gonadotrophin is in shortage

Why Human-Menopausal-Gonadotrophin is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Human-Menopausal-Gonadotrophin status changes